The single-center report echoes the findings of larger studies and supports efforts to increase gender diversity among ...

Quantifying where there are gaps between need and supply could ultimately help bystanders act fast when cardiac arrest occurs ...

It was initially thought Lp(a) would need to be measured only once, but data suggest it can fluctuate in some people.

Increasing delays in access to in-person office evaluation with physicians leads to the development of a new virtual care ecosystem.

Whether to use ATP is not clear-cut and the choice should be made through shared decision-making, one expert says.

Surviving a SARS-CoV-2 infection may be a reason to be more vigilant about general CV prevention measures moving forward.

The interconnection is far deeper than previously thought, raising new ways to promote health, says Fernando Testai.

CCCTN registry data reinforce the message that DanGer Shock’s findings supporting MCS apply narrowly to patients studied.

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.

It’s time for an endpoint that includes quality of life and mortality, and weights events accordingly, says one surgeon.

The experts provide a how-to on dealing with sticky situations, such as no-flow and large thrombus, during PCI for STEMI.

The data shed more light on how patients in the real world are faring after CAR T-cell treatment, says Sarju Ganatra.